The weekly injection is now the first drug treatment option cleared for patients with obesity and moderate-to-severe ...
Eli Lilly (LLY) has announced it will make lower-priced, single-dose vials of its popular weight-loss treatment Zepound available on telehealth platform Ro. Starting today, consumers can get an ...
Zepound manufacturer Eli Lilly released results from their SURMOUNT-5 phase clinical trial on Wednesday which is the first time both GLP1s have been compared side-by-side. Both drugs mimic the GLP ...
According to Lilly’s trial results, patients who got weekly injections of Zepbound lost ... the most commonly reported side effects for both Zepound and Wegovy were gastrointestinal-related ...